Neuphoria Therapeutics Inc. Operating Lease Liability
Neuphoria Therapeutics Inc. (NEUP) had Operating Lease Liability of $0 as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-05-15
- 2026-03-31: Operating Lease, Liability $0.00.
- 2025-12-31: Operating Lease, Liability $0.00.
- 2025-09-30: Operating Lease, Liability $85.21K.
- 2025-06-30: Operating Lease, Liability $116.31K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-17 |
| 2025-09-30 | $85.21K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $116.31K 10-K · filed 2025-09-29 |
| 2025-03-31 | $141.06K 10-Q · filed 2025-05-20 |
| 2024-12-31 | $168.31K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $219.35K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $239.62K 10-K · filed 2024-09-30 |
| 2023-06-30 | $353.76K 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |